查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602721

肛瘺治療市場：依治療類型、肛門瘺類型、最終用戶分類 - 全球預測 2025-2030

Anal Fistula Treatment Market by Treatment Type (Non-Surgical, Surgical), Fistula Type (Intersphincteric Fistula, Suprasphincteric Fistula, Transsphincteric Fistula), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，痔瘡治療市場價值為6.5139億美元，預計到2024年將達到6.7552億美元，複合年成長率為4.87%，到2030年將達到9.091億美元。

肛瘺治療市場圍繞著旨在治療肛門瘺的醫療干預措施，肛瘺是肛管和皮膚之間的異常連接。由於肛瘺帶來的不適、潛在併發症和高復發率，因此需要有效的治療方案，這凸顯了對創新和有效治療方案的迫切需求。應用範圍和最終用途主要包括醫院、診所和專科手術中心，其中先進的外科手術如瘻管塞、LIFT（括約肌間瘻管結紮術）、VAAFT（視訊輔助肛瘺治療）和微創技術正在獲得應用受歡迎程度。市場成長受到手術技術進步、肛門疾病盛行率增加以及對直腸健康意識不斷增強等因素的影響。新的商機包括開發用於外科植入的新型生物材料以及增強微創手術以降低復發和術後併發症的風險。利用這些機會的主要建議包括促進與醫學研究機構的合作以及增加研發投資以產生具有成本效益的解決方案。然而，仍存在一些挑戰，包括手術的複雜性、失禁的風險以及缺乏獲得專門護理的機會，特別是在低收入地區。創新可以集中在更安全的手術黏劑、用於更好診斷的影像技術的進步以及針對患者特定肛門瘺特徵的個人化醫療方法。該市場是由醫療保健支出增加和技術創新推動的，但成長受到認知有限和潛在治療副作用的限制。相關人員應優先考慮教育舉措並制定應對臨床挑戰的策略，以確保尖端解決方案保持可近性和有效性。

主要市場統計
基準年[2023] 65139萬美元
預測年份 [2024] 67552萬美元
預測年份 [2030] 9.091 億美元
複合年成長率（%） 4.87%

市場動態：揭示快速發展的肛瘺治療市場的關鍵市場洞察

供需的動態交互作用正在改變痔瘡治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球痔瘡盛行率不斷上升
    • 傾向微創手術
    • 提高肛瘺治療藥物和治療方法的核准率
  • 市場限制因素
    • 肛瘺治療高成本
  • 市場機會
    • 採用治療方法
    • 用於開發增強藥物和治療方法的大量投資和資金籌措
  • 市場問題
    • 肛瘺治療相關併發症

波特五力：駕馭肛門瘺治療市場的策略工具

波特的五力框架是了解肛門瘺治療市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肛門瘺治療市場的外在影響

外部宏觀環境因素在塑造肛瘺治療市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解肛瘺治療市場的競爭狀況

對痔瘡治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：肛門瘺治療市場供應商的績效評估

FPNV 定位矩陣是評估肛門瘺治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃肛瘺治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對痔瘡治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地肛瘺的盛行率正在增加。
      • 微創手術趨勢
      • 提高肛瘺治療藥物和治療方法的核准率
    • 抑制因素
      • 治療痔瘡費用高
    • 機會
      • 採用新的肛門瘺治療方法
      • 用於開發增強藥物和治療方法的大量投資和資金
    • 任務
      • 肛瘺治療相關併發症
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章肛瘺治療市場：依治療類型

  • 介紹
  • 非手術手術
  • 外科手術

第7章肛瘺治療市場：按肛瘺類型

  • 介紹
  • 括約肌間肛門瘺
  • 肛門上括約肌肛瘺
  • 括約肌穿透性肛門瘺

第8章肛瘺治療市場：依最終使用者分類

  • 介紹
  • 門診手術中心
  • 醫院

第9章北美和南美肛門瘺治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肛瘺治療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲肛門瘺治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Cook Group Incorporated
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Novartis AG
  • Pfizer Inc.
  • Signum Surgical
  • Surtex Instruments Limited
  • Takeda Pharmaceutical Company Limited
  • THD SpA
  • WL Gore & Associates, Inc.
Product Code: MRR-8E22B61932B3

The Anal Fistula Treatment Market was valued at USD 651.39 million in 2023, expected to reach USD 675.52 million in 2024, and is projected to grow at a CAGR of 4.87%, to USD 909.10 million by 2030.

The anal fistula treatment market revolves around medical interventions aimed at managing anal fistulas, which are abnormal connections between the anal canal and the skin. The necessity for effective treatment solutions is driven by the discomfort, potential complications, and high recurrence rates associated with anal fistulas, highlighting the critical need for innovative and efficient therapeutic options. The application and end-use scope primarily involve hospitals, clinics, and specialty surgery centers, where advanced surgical procedures and minimally invasive techniques such as Fistula Plug, LIFT (Ligation of Intersphincteric Fistula Tract), and VAAFT (Video Assisted Anal Fistula Treatment) are gaining traction. Market growth is influenced by factors such as technological advancements in surgical techniques, increasing prevalence of anal conditions, and greater awareness of rectal health. Emerging opportunities include the development of novel biomaterials for surgical implants and enhanced minimally invasive procedures, which may present less risk of recurrence and post-operative complications. Key recommendations to harness these opportunities involve fostering collaboration with medical research institutions and increasing investment in R&D to create cost-effective solutions. However, several challenges persist, such as the complexity of surgical procedures, risk of incontinence, and lack of widespread access to specialized treatment, especially in low-income regions. Innovation could focus on the formulation of safer surgical adhesives, advances in imaging techniques for better diagnosis, and personalized medicine approaches that address patient-specific fistula characteristics. The market is anticipated to evolve, driven by growing healthcare expenditure and technological innovation, yet its growth is curtailed by limited awareness and potential side effects of treatments. Stakeholders should prioritize educational initiatives and develop strategies to address clinical challenges, ensuring that cutting-edge solutions remain approachable and effective.

KEY MARKET STATISTICS
Base Year [2023] USD 651.39 million
Estimated Year [2024] USD 675.52 million
Forecast Year [2030] USD 909.10 million
CAGR (%) 4.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anal Fistula Treatment Market

The Anal Fistula Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of anal fistula among individuals worldwide
    • Inclination towards minimally invasive surgical procedure
    • Rise in approval rate for drugs and therapies for anal fistula treatment
  • Market Restraints
    • High cost of anal fistula treatment
  • Market Opportunities
    • Introduction of novel treatments for anal fistula
    • Significant investment and funding for development of enhanced drugs and treatments
  • Market Challenges
    • Complications associated with anal fistula treatment

Porter's Five Forces: A Strategic Tool for Navigating the Anal Fistula Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anal Fistula Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anal Fistula Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anal Fistula Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anal Fistula Treatment Market

A detailed market share analysis in the Anal Fistula Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anal Fistula Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anal Fistula Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anal Fistula Treatment Market

A strategic analysis of the Anal Fistula Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anal Fistula Treatment Market, highlighting leading vendors and their innovative profiles. These include Cook Group Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Novartis AG, Pfizer Inc., Signum Surgical, Surtex Instruments Limited, Takeda Pharmaceutical Company Limited, THD SpA, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Anal Fistula Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Non-Surgical and Surgical.
  • Based on Fistula Type, market is studied across Intersphincteric Fistula, Suprasphincteric Fistula, and Transsphincteric Fistula.
  • Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of anal fistula among individuals worldwide
      • 5.1.1.2. Inclination towards minimally invasive surgical procedure
      • 5.1.1.3. Rise in approval rate for drugs and therapies for anal fistula treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anal fistula treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel treatments for anal fistula
      • 5.1.3.2. Significant investment and funding for development of enhanced drugs and treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with anal fistula treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anal Fistula Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
  • 6.3. Surgical

7. Anal Fistula Treatment Market, by Fistula Type

  • 7.1. Introduction
  • 7.2. Intersphincteric Fistula
  • 7.3. Suprasphincteric Fistula
  • 7.4. Transsphincteric Fistula

8. Anal Fistula Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Anal Fistula Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anal Fistula Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anal Fistula Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cook Group Incorporated
  • 2. Integra LifeSciences Corporation
  • 3. Johnson & Johnson Services, Inc.
  • 4. KARL STORZ SE & Co. KG
  • 5. Novartis AG
  • 6. Pfizer Inc.
  • 7. Signum Surgical
  • 8. Surtex Instruments Limited
  • 9. Takeda Pharmaceutical Company Limited
  • 10. THD SpA
  • 11. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. ANAL FISTULA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANAL FISTULA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANAL FISTULA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANAL FISTULA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY INTERSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY SUPRASPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TRANSSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023